Use of Chlorhexidine Preparations in Total Joint Arthroplasty

Prosthetic joint infection (PJI) is a serious complication after total joint arthroplasty (TJA). Chlorhexidine is a widely used antiseptic because of its rapid and persistent action. It is well tolerated and available in different formulations at various concentrations. Chlorhexidine can be used for...

Full description

Saved in:
Bibliographic Details
Published inJournal of bone and joint infection Vol. 2; no. 1; pp. 15 - 22
Main Authors George, Jaiben, Klika, Alison K, Higuera, Carlos A
Format Journal Article
LanguageEnglish
Published Australia Ivyspring International Publisher 2017
Copernicus Publications
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Prosthetic joint infection (PJI) is a serious complication after total joint arthroplasty (TJA). Chlorhexidine is a widely used antiseptic because of its rapid and persistent action. It is well tolerated and available in different formulations at various concentrations. Chlorhexidine can be used for pre-operative skin cleansing, surgical site preparation, hand antisepsis of the surgical team and intra-articular irrigation of infected joints. The optimal intra-articular concentration of chlorhexidine gluconate in irrigation solution is 2%, to provide a persistent decrease in biofilm formation, though cytotoxicity might be an issue. Although chlorhexidine is relatively cheap, routine use of chlorhexidine without evidence of clear benefits can lead to unnecessary costs, adverse effects and even emergence of resistance. This review focuses on the current applications of various chlorhexidine formulations in TJA. As the treatment of PJI is challenging and expensive, effective preparations of chlorhexidine could help in the prevention and control of PJI.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Competing Interests: The authors have declared that no competing interest exists.
ISSN:2206-3552
2206-3552
DOI:10.7150/jbji.16934